Phil L'Huillier, Scancell CEO, on the Latest ...

Pancreatic cancer has the lowest survival rate of any major cancer — just 13%, largely because it's so hard to catch early. Changing that takes more than a lab breakthrough. It takes the unglamorous infrastructure to collect, track, and safeguard patient samples across dozens of ...  Show more

This debut video episode of the In Vivo podcast examines the successes and pitfalls of the commercial launch of Yescarta (axicabtagene ciloleucel), Kite Pharma’s CAR-T therapy for relapsed/refractory large B-cell lymphoma. David Wild, senior reporter at In Vivo, is joined by Harr ...  Show more

Kara Swisher, Host of "Sway" and "Pivot" podcasts, Contributing Opinion Writer for NYT, and Co-Founder of Recode, joins Dan Loney to talk about last week's Wharton Analytics Conference during which she spoke about algorithms, how the pandemic has accelerated certain tech trends, ...  Show more

Innovation and interest in the tech sector remain strong, despite market challenges and dips in investment. On this episode of The McKinsey Podcast, McKinsey technology experts Lareina Yee and Roger Roberts share findings from the McKinsey Technology Trends Outlook 2024 report. T ...  Show more

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ...

2021 was a busy year for IIBA (International Institute of Business Analysis). In this episode Scott and Susan talk about 2021 news, trends and updates from IIBA and we talk about the things coming up in 2022 for our organization. 

Click to learn more about the topi ...